SCI时时刷

search
A case of hemophagocytic lymphohistiocytosis following second dose of COVID-19 vaccination
A case of hemophagocytic lymphohistiocytosis following second dose of COVID-19 vaccination
Hemophagocytic lymphohistiocytosis (HLH) is a rare, severe hyperinflammatory disease characterized by overproduction of cy...
High rates of anti-αIIbβ3 antibodies produced by a Glanzmann thrombasthenia patient after first and unique red blood cells administration
High rates of anti-αIIbβ3 antibodies produced by a Glanzmann thrombasthenia patient after first and unique red blood cells administration
Immunization against the platelet αIIbβ3 glycoprotein due to blood transfusion represents one of the most severe complicat...
Monitoring Minimal Residual Disease in RUNX1-Mutated Acute Myeloid Leukemia
Monitoring Minimal Residual Disease in RUNX1-Mutated Acute Myeloid Leukemia
<b><i>Introduction:</i></b> Mutated RUNX1 is considered a poor prognostic factor and usually is mu...
A gene signature comprising seven pyroptosis-related genes predicts prognosis in pediatric patients with acute myeloid leukemia
A gene signature comprising seven pyroptosis-related genes predicts prognosis in pediatric patients with acute myeloid leukemia
Introduction: To construct a pyroptosis-related risk score (RS) model for the prognosis of acute myeloid leukemia (AML). M...
Monitoring minimal residual disease in RUNX1-mutated acute myeloid leukemia
Monitoring minimal residual disease in RUNX1-mutated acute myeloid leukemia
Introduction: Mutated RUNX1 is considered a poor prognostic factor and usually is mutually exclusive with NPM1 mutations. ...
Prevalence and Clinical Characteristics of Paraproteinemia Associated with Chronic Myeloid Leukemia
Prevalence and Clinical Characteristics of Paraproteinemia Associated with Chronic Myeloid Leukemia
Introduction: Data regarding the prevalence of paraproteinemia in patients with chronic myeloid leukemia (CML) are lacking...
Treatment-free remission in real-world chronic myeloid leukemia patients: Insights from German hematology practices
Treatment-free remission in real-world chronic myeloid leukemia patients: Insights from German hematology practices
Introduction Treatment-free remission (TFR) is increasingly considered as treatment goal for patients with chronic myeloid...
Detection and gene mutation analysis of three variations in two unrelated Chinese hereditary coagulation factor XI deficiency families
Detection and gene mutation analysis of three variations in two unrelated Chinese hereditary coagulation factor XI deficiency families
Objectives: Three variations including a novel F11 gene variation were detected in two unrelated Chinese families with coa...
Breaking stereotypes - Polycythemia secondary to shisha smoking in a middle-age Swiss woman
Breaking stereotypes - Polycythemia secondary to shisha smoking in a middle-age Swiss woman
The diagnosis of polycythemia, particularly the secondary forms, can be challenging. The distinction between primary and s...
A novel ANK1 mutation in a neonatal hereditary spherocytosis case: Diagnostic challenges and familial genetic analysis
A novel ANK1 mutation in a neonatal hereditary spherocytosis case: Diagnostic challenges and familial genetic analysis
Hereditary spherocytosis (HS) is a congenital disease in which erythrocyte membranes are abnormal, with ANK1 defects as th...
A Phase II Study of Azacitidine, Venetoclax and Trametinib in Relapsed or Refractory AML Harboring RAS Pathway-Activating Mutations
A Phase II Study of Azacitidine, Venetoclax and Trametinib in Relapsed or Refractory AML Harboring RAS Pathway-Activating Mutations
Introduction: RAS pathway mutations are common mechanisms of resistance to acute myeloid leukemia (AML) therapies. Trameti...
Gilteritinib in Isolated Breast Relapse of FLT3 Positive Acute Myeloid Leukemia: A Case Report and Review of Literature
Gilteritinib in Isolated Breast Relapse of FLT3 Positive Acute Myeloid Leukemia: A Case Report and Review of Literature
Extramedullary relapse of acute myeloid leukemia (AML) is not a rare event, and the FMS-like tyrosine kinase 3 (<i>F...
Gilteritinib in Isolated Breast Relapse of FLT3 Positive Acute Myeloid Leukemia: A Case Report and Review of Literature
Gilteritinib in Isolated Breast Relapse of FLT3 Positive Acute Myeloid Leukemia: A Case Report and Review of Literature
Extramedullary relapse of acute myeloid leukemia (AML) is not a rare event and FMS-like tyrosine kinase 3 (FLT3) mutation ...
Successful treatment of the TEMPI syndrome with pomalidomide plus dexamethasone followed by autologous stem cell transplantation
Successful treatment of the TEMPI syndrome with pomalidomide plus dexamethasone followed by autologous stem cell transplantation
TEMPI syndrome is a rare disease associated with plasma cell neoplasms. Although previous studies have reported that borte...
A Systematic Review Assessing the Underrepresentation of Cancer Patients in COVID-19 Trials
A Systematic Review Assessing the Underrepresentation of Cancer Patients in COVID-19 Trials
<b><i>Background:</i></b> The new severe acute respiratory syndrome coronavirus 2 has emerged as a...
Gilteritinib in isolated breast relapse of FLT3positive acute myeloid leukemia: a case report and review of literature
Gilteritinib in isolated breast relapse of FLT3positive acute myeloid leukemia: a case report and review of literature
Extramedullary relapse of acute myeloid leukemia (AML) is not a rare event and FMS-like tyrosine kinase 3 (FLT3) mutation ...
Acquired Factor V Deficiency: A New Cause of Bleeding in Patients with Chronic Myeloid Leukemia and Extreme Leukocytosis?
Acquired Factor V Deficiency: A New Cause of Bleeding in Patients with Chronic Myeloid Leukemia and Extreme Leukocytosis?
Bleeding complications in patients with MPNs are known to be related to acquired von Willebrand disease or platelet dysfun...
A systematic review assessing the under-representation of cancer patients in COVID-19 trials
A systematic review assessing the under-representation of cancer patients in COVID-19 trials
Background - The new severe acute respiratory syndrome coronavirus 2 have emerged as a global pandemic that threatens thou...
Small RNA SequencingReveals Exosomal miRNAs as Unique Feature Markers in Unprovoked Venous Thromboembolism
Small RNA SequencingReveals Exosomal miRNAs as Unique Feature Markers in Unprovoked Venous Thromboembolism
Introduction: Venous thromboembolism (VTE) is a common cardiovascular disease. miRNAs play a key role in VTE; however, th...
Small RNA sequencing reveals exosomal miRNAs as unique feature markers in unprovoked venous thromboembolism
Small RNA sequencing reveals exosomal miRNAs as unique feature markers in unprovoked venous thromboembolism
Introduction: Venous thromboembolism (VTE) is a common cardiovascular disease. miRNAs play a key role in VTE; however, th...
Myeloid Neoplasm with PCM1-PDGFRB Transcript Responded to Low-Dose Imatinib: One Case Report with Literature Review
Myeloid Neoplasm with PCM1-PDGFRB Transcript Responded to Low-Dose Imatinib: One Case Report with Literature Review
Through an RNA-seq analysis of an adult patient with unclassifiable myelodysplastic/myeloproliferative neoplasms (MDS/MPN-...